Your browser doesn't support javascript.
loading
ACR Appropriateness Criteria® Movement Disorders and Neurodegenerative Diseases.
Harvey, H Benjamin; Watson, Laura C; Subramaniam, Rathan M; Burns, Judah; Bykowski, Julie; Chakraborty, Santanu; Ledbetter, Luke N; Lee, Ryan K; Pannell, Jeffrey S; Pollock, Jeffrey M; Powers, William J; Rosenow, Joshua M; Shih, Robert Y; Slavin, Konstantin; Utukuri, Pallavi S; Corey, Amanda S.
Afiliação
  • Harvey HB; Massachusetts General Hospital, Boston, Massachusetts. Electronic address: hbharvey@mgh.harvard.edu.
  • Watson LC; Research Author, Massachusetts General Hospital, Boston, Massachusetts.
  • Subramaniam RM; UT Southwestern Medical Center, Dallas, Texas.
  • Burns J; Panel Chair, Montefiore Medical Center, Bronx, New York.
  • Bykowski J; UC San Diego Health, San Diego, California.
  • Chakraborty S; Ottawa Hospital Research Institute and the Department of Radiology, The University of Ottawa, Ottawa, Ontario, Canada; Canadian Association of Radiologists.
  • Ledbetter LN; University of Kansas Medical Center, Kansas City, Kansas.
  • Lee RK; Einstein Healthcare Network, Philadelphia, Pennsylvania.
  • Pannell JS; University of California San Diego Medical Center, San Diego, California.
  • Pollock JM; Oregon Health & Science University, Portland, Oregon.
  • Powers WJ; University of North Carolina School of Medicine, Chapel Hill, North Carolina; American Academy of Neurology.
  • Rosenow JM; Northwestern University Feinberg School of Medicine, Chicago, Illinois; Neurosurgery expert.
  • Shih RY; Walter Reed National Military Medical Center, Bethesda, Maryland.
  • Slavin K; UIC Medical Center, Chicago, Illinois; Neurosurgery expert.
  • Utukuri PS; Columbia University Medical Center, New York, New York.
  • Corey AS; Specialty Chair, Atlanta VA Health Care System and Emory University, Atlanta, Georgia.
J Am Coll Radiol ; 17(5S): S175-S187, 2020 May.
Article em En | MEDLINE | ID: mdl-32370961
ABSTRACT
Movement disorders and neurodegenerative diseases are a variety of conditions that involve progressive neuronal degeneration, injury, or death. Establishing the correct diagnosis of a movement disorder or neurodegenerative process can be difficult due to the variable features of these conditions, unusual clinical presentations, and overlapping symptoms and characteristics. MRI has an important role in the initial assessment of these patients, although a combination of imaging and laboratory and genetic tests is often needed for complete evaluation and management. This document summarizes the imaging appropriateness data for rapidly progressive dementia, chorea, Parkinsonian syndromes, suspected neurodegeneration with brain iron accumulation, and suspected motor neuron disease. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Transtornos dos Movimentos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Transtornos dos Movimentos Idioma: En Ano de publicação: 2020 Tipo de documento: Article